225 related articles for article (PubMed ID: 12534775)
41. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ
Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
[TBL] [Abstract][Full Text] [Related]
42. Interaction of aflatoxin and hepatitis B virus in the pathogenesis of hepatocellular carcinoma.
Rajagopalan MS; Busch MP; Blum HE; Vyas GN
Life Sci; 1986 Oct; 39(14):1287-90. PubMed ID: 3020328
[TBL] [Abstract][Full Text] [Related]
43. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
[TBL] [Abstract][Full Text] [Related]
44. Environmental factors and risk for hepatocellular carcinoma.
Yu MC; Yuan JM
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S72-8. PubMed ID: 15508106
[TBL] [Abstract][Full Text] [Related]
45. Aflatoxin and liver cancer in Sudan.
Omer RE; Bakker MI; van't Veer P; Hoogenboom RL; Polman TH; Alink GM; Idris MO; Kadaru AM; Kok FJ
Nutr Cancer; 1998; 32(3):174-80. PubMed ID: 10050268
[TBL] [Abstract][Full Text] [Related]
46. [Role of environmental factors in the etiology of hepatocellular carcinoma].
Tornai I
Orv Hetil; 2010 Jul; 151(28):1132-6. PubMed ID: 20570793
[TBL] [Abstract][Full Text] [Related]
47. [Epidemiology of hepatocellular carcinoma].
Ricca Rosellini S; Miglio F
Minerva Gastroenterol Dietol; 1991; 37(2):73-84. PubMed ID: 1660311
[TBL] [Abstract][Full Text] [Related]
48. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
[TBL] [Abstract][Full Text] [Related]
49. Relation between aflatoxin, hepatitis-B virus, and hepatocellular carcinoma.
Lutwick LI
Lancet; 1979 Apr; 1(8119):755-7. PubMed ID: 85994
[TBL] [Abstract][Full Text] [Related]
50. Does hepatitis B virus cause hepatocellular carcinoma?
Trichopoulos D; Kremastinou J; Tzonou A
IARC Sci Publ; 1982; (39):317-32. PubMed ID: 6295934
[TBL] [Abstract][Full Text] [Related]
51. Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk.
Groopman JD; Johnson D; Kensler TW
Cancer Biomark; 2005; 1(1):5-14. PubMed ID: 17192028
[TBL] [Abstract][Full Text] [Related]
52. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
53. Urinary aflatoxin levels, hepatitis-B virus infection and hepatocellular carcinoma in Taiwan.
Hatch MC; Chen CJ; Levin B; Ji BT; Yang GY; Hsu SW; Wang LW; Hsieh LL; Santella RM
Int J Cancer; 1993 Jul; 54(6):931-4. PubMed ID: 8392983
[TBL] [Abstract][Full Text] [Related]
54. The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India.
Anitha S; Raghunadharao D; Waliyar F; Sudini H; Parveen M; Rao R; Kumar PL
Mutat Res Genet Toxicol Environ Mutagen; 2014 May; 766():23-8. PubMed ID: 24657665
[TBL] [Abstract][Full Text] [Related]
55. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
[TBL] [Abstract][Full Text] [Related]
56. Prevention of hepatitis B virus infection and liver cancer.
Chang MH
Recent Results Cancer Res; 2014; 193():75-95. PubMed ID: 24008294
[TBL] [Abstract][Full Text] [Related]
57. Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure.
Turner PC; Sylla A; Kuang SY; Marchant CL; Diallo MS; Hall AJ; Groopman JD; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2053-5. PubMed ID: 16103461
[TBL] [Abstract][Full Text] [Related]
58. [Epidemiology of malignant liver tumors].
Rodella S; Picoco C
Ann Ist Super Sanita; 1996; 32(4):595-610. PubMed ID: 9382428
[TBL] [Abstract][Full Text] [Related]
59. Aflatoxins, hepatocellular carcinoma and public health.
Magnussen A; Parsi MA
World J Gastroenterol; 2013 Mar; 19(10):1508-12. PubMed ID: 23539499
[TBL] [Abstract][Full Text] [Related]
60. Keap1 eye on the target: chemoprevention of liver cancer.
Yates MS; Kensler TW
Acta Pharmacol Sin; 2007 Sep; 28(9):1331-42. PubMed ID: 17723167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
